An interventional study of H2GO! in Childhood Obesity, sponsored by Boston University. Completed at 1 site in United States. Open to participants aged 9 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Boston University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 558 studies in Pediatric Obesity with a site in United States — 72 open to participants now, 109 under way, 3 of them phase 3. Pediatric Obesity · United States.
Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 39th largest by enrollment of the 475 interventional ones that give a count, is one of 24 that started in 2020, is one of 423 with no phase, and was the 340th registered.
1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.
Browse Pediatric Obesity studies →72 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 10–15
Children's Hospital Los Angeles · Sites in United States
Ages 12–18
Virginia Commonwealth University · Sites in United States
Ages 12–15 · Healthy volunteers
University of Michigan · Sites in United States
Ages 4 mo+ · Healthy volunteers
Russell McCulloh, MD · Sites in United States
Ages 12–17
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.
This study: 9 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
558 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 27 · Phase 3 10 · Phase 4 11
First in 1998; this study’s year is marked. 24 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 820 is above the median of 100 across 872 interventional studies indexed under Pediatric Obesity.
Median enrollment 95 across the 475 interventional studies, 120 across the 81 observational. Of the 419 that completed or were terminated, 116 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 558 have an industry lead sponsor. The 10 most frequent:
Boston University is the lead sponsor of 271 studies on the registry; 37 are open to participants now.
Of its 31 completed or terminated interventional studies of FDA-regulated products, 24 (77%) have results posted.
Boston University has 1 study filed under Pediatric Obesity — fewer than ten, so there is no comparison to draw.
39 of the studies in Pediatric Obesity with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04974554Medical University of South CarolinaFIT Families Multicomponent Obesity Intervention for African American Adolescents | 2026-11-30 |
| NCT06810557Temple UniversityBrief Behavioral Sleep Intervention for Obesity Prevention in Primary Care | 2026-11-30 |
| NCT04971044Vanderbilt University Medical CenterCompetency Based Approaches for Community Health 2 | 2026-12 |
| NCT05067621Yale UniversitySemaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease | 2026-12 |
| NCT04128995Children's Hospital Medical Center, CincinnatiSurgical or Medical Treatment | 2026-12 |
Add all 39 to your calendar (.ics) → With an account.
Among the 558 studies in Pediatric Obesity with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This proposal involves a collaboration with the Massachusetts Alliance of Boys and Girls Clubs. The goal is to evaluate the efficacy of youth empowerment intervention targeting sugar-sweetened beverage consumption on childhood obesity among youth. The 12-session 6-week intervention consists of health and narrative sessions and youth-led activities. For this cluster randomized controlled trial (RCT) at 10 sites, the investigators plan to recruit 45 parent-child pairs per site for a total of 450 parent-child pairs/dyads. The primary outcome is child participants' body mass index (BMI) z scores. Secondary outcomes include children's sugar-sweetened beverage intake, water intake, and youth empowerment. Change in outcomes over time among participants in the intervention sites will be compared to change in outcomes over time among participants
Over one-third of children in the U.S. are overweight or obese and at risk for short-term and long-term health consequences, including diabetes, hypertension, heart disease and certain types of cancer. Substantial evidence exists on reducing sugar-sweetened beverage (SSB) consumption as a critical dietary target for childhood obesity prevention. Efficacious behavioral interventions targeting SSBs are lacking, particularly among low-income and ethnic minority early and pre-adolescent youth who have higher SSB intake and obesity risk. Youth empowerment interventions hold potential for catalyzing behavior change in childhood obesity intervention contexts and may be particularly engaging for low-income and ethnic minority youth. However, few studies of youth empowerment health interventions have utilized rigorous study designs or examined empowerment as a mediator/mechanism of change. To this gap, the research team has worked collaboratively with Boys and Girls Clubs of America (BGCs), a national system of after-school care that reaches 4 million youth annually, to develop and pilot-test a community-based youth empowerment intervention on reducing SSB intake and preventing childhood obesity. Grounded in Empowerment Theory, the intervention targets SSB consumption through health sessions that empower youth through developing their confidence and skills; narrative sessions that empower youth through cultivating critical thinking, and youth-led activities that empower youth through opportunities to produce change within their families. The resulting H2GO! intervention is designed to be delivered within BGCs by BGC staff. Building on the successful pilot study of H2GO!, the research team is now positioned to test the efficacy of the H2GO! intervention in collaboration with the BGC network in Massachusetts, which collectively serves over 160,000 children each year. Using a cluster-randomized design, a total of 10 BGC sites will be randomly assigned to the H2GO! intervention or a wait-list, usual care condition. A total of 450 parent-child pairs (N=45 parent-child dyads per site) will be enrolled. Data will be collected at baseline, 2 months, 6 months, and 12 months and include child anthropometrics, SSB and water intake, and youth empowerment.
Specific aims of the proposal include: 1) test the efficacy of the H2GO! intervention on child BMI z scores using a cluster randomized controlled trial; 2) test the efficacy of the H2GO! intervention on child SSB and water intake; 3) examine youth empowerment as a mediator of intervention effects. Findings from this proposal will provide evidence of youth empowerment as an approach to reduce SSB intake and obesity risk and contribute to a long-term goal of producing an intervention model for childhood obesity prevention that is well-positioned for dissemination through youth-based settings.
Child participant inclusion criteria
Child participant exclusion criteria - Has a medical condition that limits ability to change beverage consumption behaviors
Parent participant inclusion criteria
Parent participant exclusion criteria
- has a medical condition that limits ability to change beverage consumption behaviors
6-week community-based behavioral program consisting of 12 group-based weekly sessions (1-hour sessions twice a week) delivered by trained staff in the Boys and Girls Club setting. The intervention targets knowledge, attitudes, and skills related to sugar-sweetened beverage consumption and water consumption, with reduction in sugar-sweetened beverage (SSB) consumption and increase in water consumption being the primary behavioral targets.
Behavioral: H2GO!
Parent-child pairs in comparison sites will receive usual care (standard Boys and Girls Club programming) during the study and the intervention upon study completion.
Child participants will participate in a 6-week behavioral intervention consisting of 12 group-based weekly sessions (1-hour sessions twice a week) delivered by trained staff in the Boys and Girls Club setting. Each week consisted of a 1-hour health session and a 1-hour narrative session (delivered on separate days). Child participants will also receive reusable water bottles and a pictorial intervention booklet, which includes worksheets and parent-child take-home activities targeting attitudes, knowledge, and skills related to sugar-sweetened beverage and water consumption. Parent participants will be exposed to intervention messages (e.g., reduce SSB intake) through weekly parent-child take-home activities, child sharing of narratives produced, and a culminating open house event.
Child Body Mass Index (BMI) z Scores
Trained staff obtained child participants' height (inches) and weight (pounds) using standardized equipment and calculated using the Centers for Disease Control (CDC) 2000 sex- and age-specific growth charts. A BMI z-score of 0 represents the age- and sex-specific population mean, with positive values indicating BMI above the reference population mean and negative values indicating BMI below the reference population mean. Lower BMI z-scores represent a more favorable outcome in this childhood obesity prevention trial, while higher BMI z-scores indicate relatively greater adiposity
Time frame: baseline, 12 months
Sugar-sweetened Beverage Intake
Sugar-sweetened beverage intake will be assessed by the self-report Beverage Intake Questionnaire (BEV-Q). Participants will report the quantity of sugar-sweetened beverages they consumed over the past day reported in fluid ounces per day.
Time frame: Baseline, 12 months
Water Intake
Water intake will be assessed by the self-report Beverage Intake Questionnaire (BEV-Q). Participants will report the quantity of water they consumed in fluid ounces per day.
Time frame: Baseline,12 months
Youth Empowerment Based on the Sociopolitical Control Scale for Youth (SPCS-Y)
This outcome was assessed with the 8-item SPCS-Y, a validated measure of youth empowerment that assesses perceived leadership competence and policy/social control. The reported value is the total score, calculated by summing responses across the eight items, using a 10-point Likert scale, with a possible score range of 8 to 80. Higher scores indicate greater youth empowerment and represent a more favorable outcome.
Time frame: Baseline,12 months
This is a cluster-randomized trial in which Boys \& Girls Club sites were the units of randomization. Dyads of parents and children were enrolled. Some parents had more than one child enrolled. Parent participants completed demographic and survey measures (e.g., health behaviors, knowledge, and attitudes) but were not assessed for child-specific outcomes such as BMI z-score.
| Milestone | Intervention | Comparison |
|---|---|---|
| Started | 440 | 380 |
| Children | 235 | 202 |
| Parents | 205 | 178 |
| Completed | 262 | 283 |
| Not completed | 178 | 97 |
| Withdrew: Lost to follow-up | 148 | 68 |
| Withdrew: Missing data for some outcome measures | 30 | 29 |
Trained staff obtained child participants' height (inches) and weight (pounds) using standardized equipment and calculated using the Centers for Disease Control (CDC) 2000 sex- and age-specific growth charts. A BMI z-score of 0 represents the age- and sex-specific population mean, with positive values indicating BMI above the reference population mean and negative values indicating BMI below the reference population mean. Lower BMI z-scores represent a more favorable outcome in this childhood obesity prevention trial, while higher BMI z-scores indicate relatively greater adiposity
| Z sccore | Intervention | Comparison |
|---|---|---|
| Baseline | 1.0 ± 1.2 | 0.8 ± 1.3 |
| 12 months | 1.0 ± 0.9 | 1.1 ± 1.1 |
Sugar-sweetened beverage intake will be assessed by the self-report Beverage Intake Questionnaire (BEV-Q). Participants will report the quantity of sugar-sweetened beverages they consumed over the past day reported in fluid ounces per day.
| fluid ounces per day | Intervention | Comparison |
|---|---|---|
| Baseline | 11.7 ± 16.9 | 12.4 ± 20.2 |
| 12 months | 6.9 ± 10.8 | 10.1 ± 13.4 |
Water intake will be assessed by the self-report Beverage Intake Questionnaire (BEV-Q). Participants will report the quantity of water they consumed in fluid ounces per day.
| ounces per day | Intervention | Comparison |
|---|---|---|
| Baseline | 24.3 ± 18.8 | 23.4 ± 18.8 |
| 12 months | 30.0 ± 18.2 | 25.1 ± 18.1 |
This outcome was assessed with the 8-item SPCS-Y, a validated measure of youth empowerment that assesses perceived leadership competence and policy/social control. The reported value is the total score, calculated by summing responses across the eight items, using a 10-point Likert scale, with a possible score range of 8 to 80. Higher scores indicate greater youth empowerment and represent a more favorable outcome.
| scores on a scale | Intervention | Comparison |
|---|---|---|
| Baseline | 53.9 ± 15.2 | 51.1 ± 15.1 |
| 12 months | 56.6 ± 16.4 | 53.7 ± 14.5 |
Collected over 12 months. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Children Intervention | 0/235 (0%) | 0/235 (0%) | 0/235 (0%) |
| Children Comparison | 0/202 (0%) | 0/202 (0%) | 0/202 (0%) |
| Parent Intervention | 0/205 (0%) | 0/205 (0%) | 0/205 (0%) |
| Parent Comparison | 0/178 (0%) | 0/178 (0%) | 0/178 (0%) |
Parent-child dyads were enrolled; however, the child was the primary participant for the trial's efficacy evaluation. Baseline characteristics reported pertain to child and parent participants. Some parents had more than one child.
| Age, Continuous(years) | Children Intervention | Children Comparison | Parent Intervention | Parent Comparison | Total |
|---|---|---|---|---|---|
| Mean | 10.0 ± 1.1 | 10.2 ± 1.2 | 39.1 ± 8.1 | 38.2 ± 9.1 | 23.4 ± 15.5 |
| Sex/Gender, Customized(Participants) | Children Intervention | Children Comparison | Parent Intervention | Parent Comparison | Total |
|---|---|---|---|---|---|
| Female | 113 | 106 | 171 | 153 | 543 |
| Male | 122 | 96 | 27 | 20 | 265 |
| Unknown | 0 | 0 | 7 | 5 | 12 |
| Race/Ethnicity, Customized(Participants) | Children Intervention | Children Comparison | Parent Intervention | Parent Comparison | Total |
|---|---|---|---|---|---|
| Hispanic | 87 | 99 | 71 | 78 | 335 |
| Non Hispanic (NH) White | 83 | 46 | 76 | 61 | 266 |
| NH Black or African Am | 42 | 27 | 36 | 24 | 129 |
| NH Asian | 4 | 4 | 5 | 3 | 16 |
| NH Am Indian or Alaskan Native | 1 | 0 | 0 | 0 | 1 |
| NH Other | 18 | 26 | 8 | 8 | 60 |
| Unknown | 0 | 0 | 9 | 4 | 13 |
| Region of Enrollment(participants) | Children Intervention | Children Comparison | Parent Intervention | Parent Comparison | Total |
|---|---|---|---|---|---|
| United States | 235 | 202 | 205 | 178 | 820 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Oct 2020 to primary completion in Jun 2025, 55 months.
Results were first posted in Oct 2026, 1 year 4 months after primary completion.
Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 55 months is above that.
Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.
Completion moved once since we started tracking on Sep 25, 2026: May 2026 → Jun 2025, on Oct 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.